ThermoGenesis Announces Publishing of Results of ImmuneCyte’s Licensed Neutralizing Antibody Therapeutics for COVID-19
ThermoGenesis Holdings, Inc. (Rancho Cordova, CA, USA) has announced that the results of its joint venture ImmuneCyte Life Sciences, Inc.’s (Irvine, CA, USA) licensed, fully human neutralizing antibody therapeutics for COVID-19 have been published. More...17 Jun 2020
Preventive COVID-19 Peptide Vaccine Aims to Provide Broad and Long-Lasting Immune Response
Scientists have developed and successfully tested in silico a preventive COVID-19 peptide vaccine which is designed to elicit long-term T cell immunity in contrast to most of the vaccine candidates being developed with antibodies. More...17 Jun 2020
World’s First Quantitative Surrogate Viral Neutralization Test Evaluates COVID-19 Protective Immunity in US
The world’s first quantitative surrogate Viral Neutralization Test (sVNT) to evaluate COVID-19 protective immunity in the US will measure and quantify the neutralizing capacity of antibodies against the SARS-CoV-2 virus. More...17 Jun 2020
Bead-Assisted Mass Spectrometry (BAMS) Diagnostic Test for COVID-19 Reaches Prototype Stage
A Bead-Assisted Mass Spectrometry (BAMS) diagnostic test for COVID-19 infection that is currently under development has reached prototype stage and can detect the coronavirus spike protein in model samples in the concentration range appropriate for a clinical diagnostic test. More...16 Jun 2020
Eli Lilly Begins Phase 3 Trial to Study Potential of Rheumatoid Arthritis Drug as COVID-19 Treatment
Eli Lilly and Company (Indianapolis, Ind, USA) has enrolled the first patient in a Phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of baricitinib, an oral JAK1/JAK2 inhibitor, in hospitalized adults with COVID-19. More...16 Jun 2020
Chinese Firm Sinovac Biotech Announces Positive Early Results of COVID-19 Vaccine Trials
Sinovac Biotech Ltd. (Beijing, China) has announced positive preliminary results of Phase 1/2 clinical trial for the company’s COVID-19 vaccine candidate, named CoronaVac, which showed favorable immunogenicity and safety profiles. More...16 Jun 2020
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Standing Sling
Sara Flex
New
Plasma Freezer
iBF125-GX
In Other News
Regeneron Begins Human Trials of First Dual Antibody Cocktail for Prevention and Treatment of COVID-19
US FDA Withdraws Emergency Use Authorization for Chloroquine and Hydroxychloroquine
Broad-Spectrum Antiparasitic Drug Ivermectin Could Help `Cure` COVID-19
First True POC COVID-19 Antibody Tests Offer Convenience and Ease of Use
New POC Device Improves Speed and Accuracy of Lateral Flow Immunoassays to Detect COVID-19 IgM/IgG Antibodies
Tuberculosis and Polio Vaccines Being Tested for Limited Protection Against Coronavirus
Moderna’s COVID-19 Vaccine Appears Safe in Mouse Study with Single Dose Offering Protection
Cue Health Receives FDA Emergency Use Authorization for Rapid, Molecular POC COVID-19 Test
New Extraction-Free Saliva-Based Test Detects SARS-CoV-2 Without Using Nasal Swab
Merck and PeptiDream Collaborate to Develop Novel Peptide COVID-19 Therapies
Awareness Technology Announces Availability of Two-Plate ELISA and Chemiluminescent Analyzer
ChromaCode's High-Throughput HDPCR SARS-CoV-2 Real-Time PCR Assay Granted FDA Emergency Use Authorization
Illumina Receives First FDA Emergency Use Authorization for Sequencing-Based COVID-19 Diagnostic Test
Grifols Becomes First Company to Start Production of Anti-SARS-CoV-2 Hyperimmune Immunoglobulin
Drug Designed to Treat COVID-19 Could Be Authorized for Use as Early as September, Says Eli Lilly
Moderna Announces Progress on Late-Stage Development of mRNA COVID-19 Vaccine Candidate
PerkinElmer's Euroimmun SARS-CoV-2 Test Secures FDA Emergency User Authorization
Siemens Secures New FDA Emergency Use Authorizations for Coronavirus Antibody Test
China Begins Human Trial of Inactivated COVID-19 Vaccine After Promising Results in Animal Tests
First Novel Monoclonal Antibody Against COVID-19 Enters Clinical Trials
Sekisui’s New OSOM Ultra Plus Flu A&B Test to Help Diagnose Respiratory Infections Amid COVID-19 Pandemic
HHS Announces New Laboratory Data Reporting Guidance for COVID-19 Testing
Scientists Use Cancer Immunotherapy Tools to Identify Targets for COVID-19 Vaccine
